COMPARATIVE CLINICAL EVALUATION OF MANIBHADRA LEHA WITH AND WITHOUT PANCHATIKTA GHRITA MATRA BASTI IN EKKUSTHA PSORIASIS
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- change in clinical presentation of psoriasis assess through
研究概览
简要总结
This is an open label, comparative clinical trial to evaluate the efficacy of Manibhadra Leha with and without Panchtikta Ghrita Matra Basti in Psoriasis. A total number of 60 patient fulfilling the inclusion criteria will be randomly divided into 30 each. One group will be recieving Manibhadra Leha for 30 days and other will be recieving Manibhadra Leha for 23 days with Panchtikta Ghrita Matra Basti for 7 days.The efficacy will be assessed based on subjective symptoms like itching, erythema, scaling and PASI score along with CDQLI scale. Follow up will be done on 7th,15th,30th and 45th day of study. The aim is to compare both regimens and provide a cost effective, safe, and efficient ayurvedic intervention for Psoriasis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 5.00 Year(s) 至 16.00 Year(s)（—）
- 性别
- All
入选标准
- •Children aged between 5-16 years Patients of either sex Children having classical sign and symptoms of psoriasis.
排除标准
- •Patients below 5 years of age and above 16 years of age Patient suffering from any other chronic systemic illness and allergic disorders Patient diagnosed with any other skin disorder except psoriasis Patient not fulfilling the inclusion criteria Patient and attendant not willing to given written consent for participation Patient with any complication of psoriasis example pustular psoriasis psoriasis with arthritis.
结局指标
主要结局
change in clinical presentation of psoriasis assess through
时间窗: Base line assessment day0 | mid treatment assessment day15 | post treatment assessment day45
1. PASI Score
时间窗: Base line assessment day0 | mid treatment assessment day15 | post treatment assessment day45
2. CDQLI Score
时间窗: Base line assessment day0 | mid treatment assessment day15 | post treatment assessment day45
3. Improvement in subjective parameter like itching,scaling,erythema
时间窗: Base line assessment day0 | mid treatment assessment day15 | post treatment assessment day45
4. Change in subjective parameter like Auspitz sign, candle grease sign
时间窗: Base line assessment day0 | mid treatment assessment day15 | post treatment assessment day45
次要结局
- Improvement in scar and itching and Improvement in over all health of the patient(45 days)
研究者
Sakshi choudhary
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan